Bruce Albert Malcolm

Title: Bruce Albert Malcolm: Innovator in Viral Infection Treatments

Introduction

Bruce Albert Malcolm is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of medical science, particularly in the treatment of upper respiratory tract infections. With a total of 3 patents, Malcolm's work focuses on innovative formulations that aim to combat viral infections.

Latest Patents

One of his latest patents involves polyinosinic-polycytidylic acid (poly (I:C)) formulations designed for the treatment of upper respiratory tract infections. This invention concerns a composition comprising micro particles of polyinosinic-polycytidylic acid and a carrier polymer selected from starch, alginate, blanose, or dipalmitoylphosphatidylcholine (DPPC). The formulation is intended for use in preventing and/or treating viral infections of the upper respiratory tract or the common cold. Additionally, it includes a device, preferably a nasal delivery system, that comprises the composition for use by patients in need of prevention or treatment.

Career Highlights

Throughout his career, Bruce Albert Malcolm has worked with prominent companies in the pharmaceutical industry, including Janssen Sciences Ireland and Janssen Research & Development Ireland. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of viral infection treatments.

Collaborations

Malcolm has collaborated with several professionals in his field, including Roger Paulus, Maria Sutmuller, and Lieven Elvire Colett Baert. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Bruce Albert Malcolm is a distinguished inventor whose work in viral infection treatments has the potential to make a significant impact on public health. His innovative formulations and collaborations highlight his commitment to advancing medical science.